Daniel Rea

Publications

  1. 2010
  2. Published
  3. 2009
  4. Published
  5. Published

    Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.

    Daniel Rea, , , , , , , , , , , , , , & , 1 Jun 2009, In: International Journal of Oncology. 34, 6, p. 1629-36 8 p.

    Research output: Contribution to journalArticlepeer-review

  6. Published

    Role of Tyrosine Kinase Inhibitors in Lung Cancer

    Daniel Palmer, Daniel Rea & Syed Hussain, 1 Jun 2009, In: Anti-Cancer Agents in Medicinal Chemistry. 9, 5, p. 569-575 7 p.

    Research output: Contribution to journalArticle

  7. Published

    Genomics and pharmacogenomics in the management of breast cancer

    Jennifer Pascoe, Daniel Palmer, , Daniel Rea & Syed Hussain, 1 Mar 2009, In: Current Pharmacogenomics. 6, 1, p. 45-55 11 p.

    Research output: Contribution to journalArticle

  8. Published

    Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.

    Lucinda Billingham, , , , Daniel Rea, , , , & Keith Wheatley, 14 Feb 2009, In: Lancet. 373, 9663, p. 567-74 8 p.

    Research output: Contribution to journalArticlepeer-review

  9. 2008
  10. Published

    Acute non-myelosuppressive complications of systemic anticancer therapy

    Daniel Rea, 1 Aug 2008, In: Clinical Medicine. 8, 4, p. 439-442 4 p.

    Research output: Contribution to journalEditorial

  11. Published
  12. Published
  13. Published